Table 1.

Demographics and baseline characteristics (n = 103)

Baseline Characteristics	Mean (SD) or n (%)
Age	56 (14.2)
Gender (% male)	53 (52%)
Race
Caucasian	32 (31.4%)
African American	68 (66.7%)
other	2 (2.0%)
Etiology of ESRDa
hypertension	41 (40.2%)
diabetes	48 (47.1%)
glomerulonephritis	6 (5.9%)
cystic kidney disease	3 (2.9%)
urologic	0
other	12 (11.8%)
Years of ESRD	4.1 (3.0)
Years on hemodialysis	4.2 (2.9)
No. years of itching daily/nearly daily
not daily/nearly daily	15 (14.6%)
<1 year	27 (26.2%)
1 to 5 years	43 (41.7%)
>5 years	18 (17.5%)
Oral antihistamines (over the counter)	20 (19.4%)
Oral antihistamines (prescribed)	13 (12.3%)
IV antihistamines	8 (7.8%)
Topical antihistamines	0 (0%)
Gabapentin	14 (13.6%)
Topical corticosteroids	3 (2.9%)
IV or oral corticosteroids	4 (3.9%)
Naltrexone	1 (1%)
Topical tacrolimus	0
UVB treatment	0
Antidepressants	29 (8.1%)
Anti-anxiolytics/sedatives	24 (23.8%)
Opiods and opioid combinationb	38 (36.9%)
Nonprescription sleep aid	2 (1.9%)

^aMore than one primary etiology was reported for several patients.

^bExcluding naltrexone.